(Total Views: 404)
Posted On: 09/11/2020 4:04:03 PM
Post# of 154867
I hear ya, and I hear everyone's concerns about Nasdaq, and while I agree there are some definite benefits to it, I don't believe it will make Leronlimab any more effective.
Sure, the launch will be better on nasdaq. But 3 years from now I wont care if we uplisted in September or November.
Sure, the launch will be better on nasdaq. But 3 years from now I wont care if we uplisted in September or November.
(2)
(0)
